Featured Research

from universities, journals, and other organizations

New diagnostic technology points to possible new blood tests for conditions from Alzheimer's to autoimmune diseases

Date:
March 21, 2013
Source:
Scripps Research Institute
Summary:
Researchers have developed cutting-edge technology that can successfully screen human blood for disease markers. This tool may hold the key to better diagnosing and understanding today's most pressing and puzzling health conditions, including autoimmune diseases.

Researchers at The Scripps Research Institute (TSRI) in Jupiter, FL, have developed cutting-edge technology that can successfully screen human blood for disease markers. This tool may hold the key to better diagnosing and understanding today's most pressing and puzzling health conditions, including autoimmune diseases.

Related Articles


"This study validates that the 'antigen surrogate' technology will indeed be a powerful tool for diagnostics," said Thomas Kodadek, PhD, a professor in the Departments of Chemistry and Cancer Biology and vice chairman of the Department of Chemistry at TSRI, whose group developed the technology.

The latest study, published in the journal Chemistry & Biology on March 21, 2013, shows how the technology accurately identified human blood markers for neuromyelitis optica (NMO), a rare autoimmune disorder resembling multiple sclerosis that can result in blindness and paralysis. Following a similar study on mouse models for multiple sclerosis two years ago, the work confirms that the technique can also be successfully applied to humans.

Finding the Needle in a Haystack

The blood is filled with molecules called "antibodies" released by the immune system to defend the body against disease. Many autoimmune diseases produce antibodies specific to that disease. Identifying these disease-specific antibodies among the millions of other similar yet non-disease-specific antibodies in the blood, however, is much like finding a needle in a haystack.

Many current diagnostic methods detect disease-specific antibodies by using part of the virus, bacteria or cellular component targeted by the antibody in a patient's body, essentially "fishing" for the antibody using its distinct target as bait. Unfortunately, many disease-specific antibodies and their targets are currently unidentified.

Kodadek and his colleagues have found a way to sidestep this conundrum by substituting these unknown antibody-binding targets with biologically unnatural molecules called "peptoids." Peptoids are chain-like molecules tethered to tiny beads and extended "link by link" by the sequential addition of small chemical subunits. By using different subunits and randomizing their order, chemists can produce libraries of thousands and even millions of different peptoids quickly and easily.

These vast libraries are screened for peptoid "hits" that bind exclusively to antibodies found only in patients known to have a specific disease. "We find disease biomarkers differently [than anyone else]," explained Kodadek. "This enables new disease biomarker detection." Additionally, by using these peptoid hits to "fish" for disease-specific antibodies, the system enables disease-specific antibody detection without first knowing the antibodies' natural binding targets.

A Diagnostic Revolution

Using this technology, the group identified several peptoids that bound exclusively to antibodies in NMO patient blood serum and not healthy patients or patients with similar diseases, including multiple sclerosis, lupus, Alzheimer's disease and narcolepsy. At least one of the peptoids bound to an antibody that is well known to be associated with NMO.

The study builds on technology that the group successfully used to identify disease markers in mouse models for multiple sclerosis, introduced in a January 2011 publication in the journal Cell. "[Our latest study] is proof positive that our technology works in complex human systems as well," explained Kodadek.

Kodadek noted the new study also introduced a technical advance that increases the technology's utility, significantly improving the peptoid library screening process. This step initially involved the time-consuming and painstakingly tedious task of removing peptoids from beads and refixating them to a different solid support, called a microarray.

"This is the first time we screened peptoid libraries directly on the beads [on which they were made] instead of using microarrays," said Bindu Raveendra, PhD, staff scientist who was a first author of the study with postdoctoral researcher Wu Hao. "Previously, we could screen thousands of peptoids at a time; now, we can now screen millions. That just wasn't feasible using microarrays."

In addition to Raveendra, Hao and Kodadek, authors of the paper "Discovery Of Peptoid Ligands For Anti-Aquaporin 4 Antibodies" are Roberto Baccala and Argyrios N. Theofilopoulos of the TSRI Immunology & Microbial Science Department, M. Muralidhar Reddy and Jessica Schilke of Opko Health and Jeffrey L. Bennett of the University of Colorado School of Medicine Neurology and Ophthalmology Department.

The study was funded by a contract from the National Heart, Lung, and Blood Institute for the Stanford Proteomics Center (N01-HV-00242) and grants from the Guthy-Jackson Charitable Foundation and the National Multiple Sclerosis Society (RG4320).


Story Source:

The above story is based on materials provided by Scripps Research Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Bindu L. Raveendra, Hao Wu, Roberto Baccala, M. Muralidhar Reddy, Jessica Schilke, Jeffrey L. Bennett, Argyrios N. Theofilopoulos, Thomas Kodadek. Discovery of Peptoid Ligands for Anti-Aquaporin 4 Antibodies. Chemistry & Biology, 2013; 20 (3): 351 [link]

Cite This Page:

Scripps Research Institute. "New diagnostic technology points to possible new blood tests for conditions from Alzheimer's to autoimmune diseases." ScienceDaily. ScienceDaily, 21 March 2013. <www.sciencedaily.com/releases/2013/03/130321133110.htm>.
Scripps Research Institute. (2013, March 21). New diagnostic technology points to possible new blood tests for conditions from Alzheimer's to autoimmune diseases. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2013/03/130321133110.htm
Scripps Research Institute. "New diagnostic technology points to possible new blood tests for conditions from Alzheimer's to autoimmune diseases." ScienceDaily. www.sciencedaily.com/releases/2013/03/130321133110.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins